Skip banner and top navigation
National Heart, Lung, and Blood Institute Home Page Link to the National Institutes of Health Link to the Department of Health and Human Services
  Home » Information for Researchers » NHLBI Research and Policy Listserv

NHLBI Research and Policy Update
Number 22   October 2005
This electronic distribution list will provide updates from the NHLBI Web Site for the research community. The updates will be sent as needed, but no more than once a week.

bulletSpecial September/October Supplements

Supplement I: NIH Grant Applications—Conversion to an Electronic Submission Process

Supplement II: Reducing Regulatory Burdens Associated with Health Care and Research



bulletFunding Updates

 Please Note: Links to RFAs, PAs, and Guide Notices will take you to the NIH Web site

RFAs

RFA-DK-05-015: Small Business Technology Transfer to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (STTR [R41/R42])
 Receipt Dates: Letter of Intent, February 15, 2006
Application, March 15, 2006

RFA-DK-05-016: Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) and its Complications (SBIR [R43/R44])
 Receipt Dates: Letter of Intent, February 15, 2006
Application, March 15, 2006

Cardiovascular Cell Therapy Research Network Initiative (RFA-HL-06-001), Frequently Asked Questions

RFPs

PDF file RFP: NHLBI-HB-06-06: Phase II/III Trial of Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension - Clinical Sites

 Receipt Dates: Letter of Intent, October 26, 2005
Application, November 21, 2005

PDF file RFP: NHLBI-HB-06-04: Phase II/III Trial of Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension - Data Coordinating Center
   
PDF file Amendment 1

 Receipt Dates: Letter of Intent, October 26, 2005
Application, November 21, 2005

PDF file RFP - Amendment 1: NHLBI-HC-06-02: Hispanic Community Health Study - Field Centers

PDF file RFP - Amendment 1: NHLBI-HC-06-01: Hispanic Community Health Study - Coordinating Center

PAs

PA-06-042: Academic Research Enhancement Award (R15)

PA-06-041: NIH Support for Conferences and Scientific Meetings (R13/U13)

PAR-06-039: Dissemination and Implementation Research in Health

PA-06-034: Development of Diagnostic Screening Test for Salt Sensitivity (STTR [R41/R42])

PA-06-033: Development of Diagnostic Screening Test for Salt Sensitivity (SBIR [R43/R44])

PA-06-035: The Relationship Between Hypertension and Inflammation

PA-06-013: Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR [R43/R44])

PA-06-012:Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR [R41/R42])

PA-06-011: Integration of Heterogeneous Data Sources (SBIR [R43/R44])

PA-06-010: Integration of Heterogeneous Data Sources (STTR [R41/R42])

PA-06-009: Bioengineering Nanotechnology Initiative - SBIR (R43/R44)

PA-06-008: Bioengineering Nanotechnology Initiative (STTR [R41/R42])

PA-06-007: Small Business Technology Transfer Program Parent Announcement (STTR [R41/R42]): Electronic Submission of Grant Applications through Grants.gov

PA-06-006: Small Business Innovation Research Program Parent Announcement (SBIR [R43/R44]): Electronic Submission of Grant Applications through Grants.gov

PA-06-004: Small Business Technology Transfer to Improve The Chemistry and Targeted Delivery of RNAi Molecules (STTR [R41/R42]

PA-06-003: Small Business Innovation Research to Improve The Chemistry and Targeted Delivery of RNAi Molecules (SBIR [R43/R44]

Guide Notices

NOT-HL-06-110: Notice of the NHLBI Clinical Hematology Research Career Development Program

NOT-HL-06-107: Notice of Community-Responsive Interventions to Reduce Cardiovascular Risk in American Indians and Alaska Natives

Hurricane Related

NOT-OD-06-009: Effects of Hurricanes Katrina and Rita on IRB Operations

NOT-OD-06-006: Delays in Grant Application Submission due to Hurricane Wilma

For additional initiatives, please visit the following Web page:
NHLBI Grants and Contracts page


bulletPolicy Updates

NHLBI Update: Change in Allowed Direct Costs and Annual Increases for Program Project Grants
Changes have been made to the policy regarding direct costs and annual increases. This affects both new and competing renewal applications. For more information, please see the online policy page: Allowable Requested Direct Costs for Program Project Grants (Update)

NIH Public Access Policy
This is a reminder that NIH policy requests and strongly encourages all NIH-funded investigators to make their peer-reviewed author final manuscripts available to other researchers and the public immediately after the final date of journal publication. For more information, please check the NIH Public Access Policy Web page.

NIH Grant Application - Conversion to an Electronic Submission Process

For additional policy documents, please visit Funding / Award Policy section on the following Web page:
Funding, Training, and Policies



bulletTraining Updates

Updated Guidelines for the Applicant: Research Supplements to Promote Diversity in Health-Related Research

For more information on training and career development programs, please visit the following Web page:
Training and Career Development



bulletMeetings

List of upcoming meetings

National Heart, Lung, and Blood Advisory Council, February 1, 2006

For more information, and the most current list of upcoming meetings, please visit the following Web page:
Announcements of NHLBI Meetings, Conferences, and Events


Reports of past meetings

Working Group on Cellular and Molecular Mechanisms of Right Heart Failure, Executive Summary, October 6-7, 2005

Working Group on Genome Wide Association in NHLBI Cohorts Meeting Summary, September 12, 2005

Preventing Weight Gain in Young Adults, NHLBI Working Group Report, August 31, 2005

For more information on past meetings, please visit the following Web page:
Workshop and Meeting Summaries, and Other Scientific Reports


bulletPress Releases

Vast Majority of Adults at Risk of Becoming Overweight or Obese—Future Burden of Obesity–Related Conditions Likely to be Substantial, Warn Researchers, October 3, 2005

For additional Press Releases, please visit the following Web page:
Current Press Releases



bulletSelected NHLBI Vacancies

The NHLBI has no vacancies to highlight at this time. Note: There are often changes and additions, for the most current information, please visit the NHLBI Jobs Opportunities page.


bulletOther Items of Interest

New Limited Access Dataset: The Salmeterol or Corticosteroids (SOCS) and the Salmeterol with and without Inhaled Corticosteriods (SLIC) Trials
These two randomized, placebo-controlled, blinded clinical trials were concurrently managed to determine whether Inhaled Corticosteriod (ICS) therapy can be reduced or eliminated in patients with persistent asthma after adding a long-acting Beta 2-agonist to their treatment regimen. The results indicate that in patients with persistent asthma suboptimally controlled by triamcinolone therapy alone but whose asthma symptoms improve after addition of salmeterol, a substantial reduction (50%) in triamcinolone dose can occur without a significant loss of asthma control. However, total elimination of triamcinolone therapy results in a significant deterioration in asthma control and, therefore, cannot be recommended. (JAMA, 2001;285:2583-2593. JAMA, 2001;285:2594-2603.)

New Limited Access Dataset: The Hypertension Detection and Follow-up Program (HDFP).
This program was designed to test the efficacy of antihypertensive therapy in reducing all-cause mortality in a population-based study. The systematic effective management of hypertension has a great potential for reducing mortality for the large numbers of people with high BP in the population, including those with mild hypertension.


bulletAn Archive of the current and past issues is available on the NHLBI Web site.


Two ways to unsubscribe:
  1. Send an e-mail message to: LISTSERV@LIST.NIH.GOV
    and, in the text of your message (not the subject line), write (or copy/paste):
    SIGNOFF NHLBI-RESEARCH-POLICY-L

  2. Use the List Web Page
    A) select this link
    B) Enter your e-mail address as it appears in the To: field of the list,
    C) Enter your full name, and
    D) Select the button, Leave the list.